e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Lung cancer - clinical research: scientific pearls from the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of ALK translocations in a large cohort of non-small cell cancer patients and quality of hybridization by sampling method.
M. Perez Warnisher (Madrid, Spain)
Source:
International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Session:
Lung cancer - clinical research: scientific pearls from the bedside
Session type:
Thematic Poster
Number:
4222
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Perez Warnisher (Madrid, Spain). Prevalence of ALK translocations in a large cohort of non-small cell cancer patients and quality of hybridization by sampling method.. 4222
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Anaesthesia, sedation and tolerance (flexible and rigid bronchoscopy)
Interventional bronchoscopy in children including foreign body extraction
Related content which might interest you:
Retrospective study of treatment outcomes according to exon difference with EGFR mutations in non-small cell lung cancer patient in Korea
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Characterization of patients with non-small cell lung cancer (NSCLC) relative to its EGFR mutational status
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Cost-effectiveness of
KRAS
,
EGFR
and
ALK
testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study
Source: Eur Respir J, 51 (3) 1701467; 10.1183/13993003.01467-2017
Year: 2018
Overall survival analysis and characterization of an EGFR mutated non small cell lung cancer (NSCLC) population
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Epithelial growth factor receptor (EGFR) mutation status and the treatment of non-small cell lung cancer (NSCLC): A population based quality assurance analysis
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Quantitative detection of ALK rearrangements using droplet digital PCR (ddPCR) in liquid biopsies of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
A variant in LKB1 gene can predicts the clinical outcomes of chemotherapy in patients with non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Year: 2018
Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011
Characteristics and prognostic relevance of
p
53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005
Survival outcomes of patients diagnosed with lung adenocarcinoma with ALK gene rearrangement
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival.
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
MDM-2 gene amplification is associated with poor prognosis in operable non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002
Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Liquid biopsy for EGFR mutations in non-small cell lung cancer cases by RT-PCR
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Implementation of PD-L1 analysis among patients with non-small cell lung cancer in a single center.
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Gender differences in the expression of double strand break genes in early non-small lung cancer (NSCLC) patients
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009
FGFR1 gene aberrations and FGFR1 protein expression in squamous non-small cell lung cancer (Sq-NSCLC).
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Combined simultaneous analysis of the automated cyto-morphology and I-FISH on the same cell, as a novel method to detect a small population of lung cancer cells
Source: Eur Respir J 2006; 28: Suppl. 50, 335s
Year: 2006
Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept